Norway In-Vitro Toxicology Testing Market Size & Outlook
The in-vitro toxicology testing market in Norway is expected to reach a projected revenue of US$ 727.9 million by 2030. A compound annual growth rate of 9.3% is expected of Norway in-vitro toxicology testing market from 2024 to 2030.
The Norway in-vitro toxicology testing market generated a revenue of USD 389.9 million in 2023 and is expected to reach USD 727.9 million by 2030.
The Norway market is expected to grow at a CAGR of 9.3% from 2024 to 2030.
In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
In-vitro toxicology testing market data book summary
Market revenue in 2023
USD 389.9 million
Market revenue in 2030
USD 727.9 million
Growth rate
9.3% (CAGR from 2023 to 2030)
Largest segment
Pharmaceutical industry
Fastest growing segment
Diagnostics
Historical data
2018 - 2022
Base year
2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry
Key market players worldwide
Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc
Other key industry trends
In terms of revenue, Norway accounted for 1.3% of the global in-vitro toxicology testing market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Europe, Germany in-vitro toxicology testing market is projected to lead the regional market in terms of revenue in 2030.
UK is the fastest growing regional market in Europe and is projected to reach USD 3,892.8 million by 2030.
Factors such as stringent regulatory guidelines for preventing animal testing, increasing demand for toxicological testing procedures, and technological advancements for developing sophisticated & accurate toxicology testing methods are projected to drive the in-vitro toxicology testing market in the country.
Moreover, several investments from market players owing to growing biotechnology and pharmaceutical sectors in the country have propelled the market growth to a significant extent. For instance, in June 2022 FUJIFILM Corporation announced an investment of USD 1.6 billion to expand and enhance its global offering of cell culture manufacturing services.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In-vitro Toxicology Testing Market Outlook will help companies and investors design strategic landscapes.
Pharmaceutical Industry was the largest segment with a revenue share of 40.55% in 2023.
Horizon Databook has segmented the Norway in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
Factors such as stringent regulatory guidelines for preventing animal testing, increasing demand for toxicological testing procedures, and technological advancements for developing sophisticated & accurate toxicology testing methods are projected to drive the in-vitro toxicology testing market in the country.
Moreover, several investments from market players owing to growing biotechnology and pharmaceutical sectors in the country have propelled the market growth to a significant extent. For instance, in June 2022 FUJIFILM Corporation announced an investment of USD 1.6 billion to expand and enhance its global offering of cell culture manufacturing services.
Norway In-Vitro Toxicology Testing Market End User Outlook (Revenue, USD Million , 2018-2030)
Pharmaceutical Industry
Cosmetics And Household Products
Academic Institutes and Research Laboratories
Diagnostics
Chemicals Industry
Food Industry
Norway In-Vitro Toxicology Testing Market Technology Outlook (Revenue, USD Million , 2018-2030)
Cell Culture Tech
High Throughput Tech
Molecular Imaging
OMICS Tech
Norway In-Vitro Toxicology Testing Market Product Outlook (Revenue, USD Million , 2018-2030)
Consumables
Assays
Instruments
Software
Services
Norway In-Vitro Toxicology Testing Market Application Outlook (Revenue, USD Million , 2018-2030)
Systemic Toxicology
Dermal Toxicity
Endorine Disruption
Occular Toxicity
Others
Norway In-Vitro Toxicology Testing Market Method Outlook (Revenue, USD Million , 2018-2030)
Cellular Assay
Biochemical Assay
In Silica
Ex-vivo
Reasons to subscribe to In-vitro Toxicology Testing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In-vitro Toxicology Testing Market Outlook databook
Our clientele includes a mix of In-vitro Toxicology Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway In-vitro Toxicology Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Norway In-vitro Toxicology Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.